ArticleCancer chemotherapy and pharmacology2014

Clinical pharmacology of an atrasentan and docetaxel regimen in men with hormone-refractory prostate cancer.

Islam R Younis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.